Key dates
AbolerIS Pharma foundation
November 2019 – AbolerIS Pharma is founded by Dr. Carole Guillonneau (Director of Research CNRS) and Dr. Ignacio Anegon (Director of Research INSERM) and Dr. François-Xavier Hubert (MD, PhD) in Nantes.
Raised 2,5M$ investment
November 2020 – AbolerIS Pharma raises 2,5M$ in Seed Financing from Newton Biocapital and Turenne Santé/Sham Innovation Santé.
Press releases
AbolerIS Pharma’s co-founder Dr. Carole Guillonneau receives Albert Sezary Prize from the National Academy of Medicine.
AbolerIS Pharma signed an exclusive world-wide license with Ouest Valorisation to develop new first-in-class anti-CD45RC antibodies.
AbolerIS Pharma Raises €2.5M in Seed Financing from Newton Biocapital and Turenne Santé/Sham Innovation Santé.
AbolerIS Pharma’s co-founder Dr. Ignacio Anegon is promoted by the INSERM to the highest position in the French research system
AbolerIS Pharma Strengthens Management Team to Support Next Phases of Growth.
Events
New dates to come soon.